Skip to content
Nov 13 2020
Research

Momentum’s Terrible, Horrible, No Good, Very Bad Day!

  • Nov 13, 2020

If Momentum and Growth investors thought they were escaping 2020 unscathed, they learned otherwise on Monday. Pfizer’s promising news about a COVID-19 vaccine was met with universal excitement and investors rearranging portfolios—taking gains in long-term winners and plowing into beaten-down cyclical stocks. 

Login

For full access, please enter your credentials.
Subscribe

About The Author

Greg Swenson / Sr. Research Analyst & Co-Portfolio Manager

Greg Swenson Sr. Research Analyst & Co-Portfolio Manager

Greg is a Senior Analyst and Co-Portfolio Manager for the Leuthold Core Investment Fund, Leuthold Global Fund, Grizzly Short Fund, Leuthold Global Industries Fund, and Leuthold Select Industries Fund.

Interested in Investing in a Model?

Contact us if you are interested in investing in our ETF models.
Contact Us